Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.

Latest News

The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN
he Menarini Group continues to stand firmly by the side of the Tommasino Bacciotti Foundation
Elcin Barker Ergun, CEO of the Menarini Group, comments in a recent interview with ANSA what Menarini continues to do in the fight against the pandemi...
READ ALL NEWS »

CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN

Company Video Menarini

MENARINI PILLS OF ART

Concession granted by Italian Ministry for Cultural Heritage and Activities Read more